Latest
By Staff Report / Friday, November 22nd, 2013 / Central Coast Health Watch, Top Stories / Comments Off on Sansum Clinic now on state insurance exchange
In a big step forward for Covered California’s ability to serve residents of the Tri-Counties, Sansum Clinic said late Friday afternoon that its 23 outpatient medical clinics will serve patients who buy Anthem Blue Cross coverage on the state’s online health insurance exchange. Sansum is one of the largest primary patient care providers in Covered California’s District 12, which includes Santa Barbara, Ventura and San Luis Obispo counties.
Read More →
Latest
By Marlize van Romburgh / Thursday, November 21st, 2013 / Central Coast Health Watch, Nonprofits, South Coast, Top Stories, Tri-County Economy / Comments Off on With funds and new CEO, Neighborhood Clinics turn the corner
The struggling Santa Barbara Neighborhood Clinics nonprofit is narrowing its funding gap and has a strategic plan and new permanent CEO in place, putting it on track to become financially sustainable at a time when it looks to expand service to Goleta.
“Six months ago, we were in danger of closing our doors,” said Mark Palmer, president of the board.
Read More →
Latest
By Stephen Nellis / Friday, November 15th, 2013 / Central Coast Health Watch, Technology, Top Stories / Comments Off on Thousand Oaks cancer drug firm raises $9M
Thousand Oaks-based ImmunGene, a cancer treatment firm led by a former Amgen scientist, has raised $9 million from Ally Bridge Group, an investment group with ties to Hong Kong.
ImmunGene’s so-called antibody-cytokine fusion technology could help improve the cancer-cell targeting in therapies. President and CEO Sanjay D. Khare was formerly the scientific director at Amgen, the biotech giant. Prior to the funding, ImmunGene had received several hundred thousand dollars in federal research grants.
Antibody technologies hold promise for creating cancer treatments that do less damage to healthy cells. Molecules are crafted to mimic the body’s own immune system and bind to specific defects in cancer cells.
Read More →
Latest
By Stephen Nellis / Friday, October 18th, 2013 / Banking & Finance, Central Coast Health Watch, Technology, Top Stories, Tourism, Tri-County Public Companies / Comments Off on Gov. Brown vetoes Amgen-backed anti-biosimilars bill
Gov. Jerry Brown vetoed a bill supported by Thousand Oaks-based Amgen and other biotechnology companies that would have made it more difficult for pharmacists to dispense so-called biosimilars, the biotech industry’s analogue to generic pharmaceuticals.
Senate Bill 598, approved by both houses of the legislature, looked mostly like a procedural change to state’s pharmacy laws. If it passed, the bill would have allowed pharmacists to fill prescriptions with biosimilars that the U.S. Food and Drug Administration deems “interchangeable” with brand-name counterparts.
Read More →
Latest
By Henry Dubroff / Friday, October 11th, 2013 / Banking & Finance, Central Coast Health Watch, South Coast, Top Stories, Tri-County Economy / Comments Off on Cottage-Sansum merger on track as anti-trust filing nears
Sansum Clinic’s planned merger with Cottage Health System remains on track despite the possibility that the partial government shutdown could delay an anti-trust review of one of the region’s biggest health care deals. And the biggest physician group in Santa Barbara County says it hopes to be able to join the Covered California insurance exchange Read More →
Read More →
Latest
By Staff Report / Tuesday, October 1st, 2013 / Central Coast Health Watch, Latest news, Nonprofits / Comments Off on Sansum Diabetes Research Institute gets $2.3M grant
Sansum Diabetes Research Institute in Santa Barbara has received a $2.25 million federal grant for diabetes research. The three-year funding comes from the U.S. Department of Health and Human Services and is for Sansum to continue its work on diabetes, endocrinology and metabolic research. Sansum’s research focuses specifically on Type 1 diabetes and the creation Read More →
Read More →
